Recommendations for Artificial Intelligence Application in Continued Process Verification: A Journey Toward the Challenges and Benefits of AI in the Biopharmaceutical Industry

¹Department of Life Sciences Innovation, Stassen Pharmaconsult BV, Aerdenhout, The Netherlands;
²Data Science Department, ValGenesis Portugal, R. Castilho 50 4th Floor, 1250-071 Lisboa, Portugal;
³Aizon, Carrer de Còrsega 301, 08008 Barcelona, Spain;
⁴Department of Chemical, Biological and Environmental Engineering, School of Engineering, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain;
⁵GSK, 1250 S. Collegeville Road, Collegeville, PA 19426, USA;
⁶Vertex Pharmaceuticals, Cincinnati, OH, USA;
⁷Takeda, Zurich, Switzerland;
⁸Aizon, Carrer de Còrsega 301, 08008 Barcelona, Spain;
⁹Vaccines Technical Development, GSK, Rue De L′Institut 89, 1330 Rixensart, Walloon Brabant, Belgium; and
¹⁰Department of Chemical, Biochemical, and Environmental Engineering, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250

↵*Corresponding Author: Department of Life Sciences Innovation, Stassen Pharmaconsult BV, Aerdenhout, The Netherlands; E-mail: mmhstassen{at}gmail.com